Approval · Notice of Compliance 17209 · 2015
ADVANTAGE MULTI 10: Notice of Compliance 17209
Issued August 19, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17209
- Date
- August 19, 2015
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update, new indication
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVANTAGE MULTI 10 | 02263556 | Marketed |
| ADVANTAGE MULTI 100 | 02263564 | Marketed |
| ADVANTAGE MULTI 20 | 02263548 | Marketed |
| ADVANTAGE MULTI 55 | 02263521 | Marketed |
Medicinal ingredients
- MOXIDECTIN 10 MG per 0.4ML
- IMIDACLOPRID 40 MG per 0.4ML
- MOXIDECTIN 100 MG per 4ML
- IMIDACLOPRID 400 MG per 4ML
- MOXIDECTIN 25 MG per ML
- IMIDACLOPRID 100 MG per ML
- MOXIDECTIN 62.5 MG per 2.5ML
- IMIDACLOPRID 250 MG per 2.5ML